Author: Bret Jensen, Biotech Gems

I would pick them up if they dropped another five percent…

They’re starting to get increasingly positive analyst commentary and look attractive…

I’ve raised my cash holdings to just over 20%, as I believe lower entry points will be available by the end of summer…

Not only are shares cheap and paying a substantial dividend, but the company should boost growth in the years ahead and it has a big activist fund pushing it to create additional shareholder value…

Google could purchase one of them with its cash holdings alone…